CapsoVision, Inc (CV)
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
Sector: Electromedical & Electrotherapeutic Apparatus
Industry: Medical - Devices
CapsoVision, Inc.
No splits on record
Nothing in CV's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Revenue | $13.55M | $11.76M | $9.75M |
| YoY Growth | 15.3% | 20.5% | - |
| Cost of Revenue | $6.38M | $5.38M | $4.26M |
| Gross Profit | $7.17M | $6.38M | $5.49M |
| Gross Margin | 52.9% | 54.2% | 56.3% |
| Research and Development | $18.31M | $15.12M | $9.33M |
| Selling, General, and Administrative | $14.38M | $11.17M | $7.5M |
| Other | $0 | $0 | $0 |
| Total Operating Expenses | $32.69M | $26.29M | $16.84M |
| Operating Income (EBIT) | -$25.52M | -$19.92M | -$11.35M |
| Operating Margin | -188.3% | -169.4% | -116.3% |
| Interest Expense | $0 | $0 | $0 |
| Interest Income | $269K | $26K | $49K |
| Other Income (Expense) | $225K | $30K | $53K |
| Income Before Tax (EBT) | -$25.29M | -$19.89M | -$11.29M |
| Income Tax Expense | $24K | $11K | $11K |
| Net Income | -$25.32M | -$19.9M | -$11.3M |
| Net Income Margin | -186.8% | -169.3% | -115.9% |
| Supplementary Data | |||
| EPS | -0.54 | -0.43 | -0.29 |
| Diluted EPS | -0.54 | -0.43 | -0.29 |
| Weighted Average OS | 46.87M | 46.34M | 38.62M |
| EBITDA | -$24.95M | -$19.4M | -$10.96M |
| EBITDA Margin | -184.1% | -165.0% | -112.4% |
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Assets | |||
| Current Assets | |||
| Cash and Cash Equivalents | $10.11M | $9.32M | $14.56M |
| Short-Term Investments | $0 | $0 | $0 |
| Cash and Short-Term Investments | $10.11M | $9.32M | $14.56M |
| Accounts Receivable | $2.5M | $2M | $1.87M |
| Inventory | $2.99M | $2.63M | $2.19M |
| Other Current Assets | $1.07M | $549K | $371K |
| Total Current Assets | $16.67M | $14.85M | $19.2M |
| Long-Term Assets | |||
| Property, Plant & Equipment Net | $1.45M | $1.92M | $2.28M |
| Goodwill | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 |
| Other Long-Term Assets | $41K | $41K | $42K |
| Total Long-Term Assets | $1.5M | $1.96M | $2.33M |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $18.16M | $16.8M | $21.53M |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | $1.14M | $749K | $361K |
| Short-Term Debt | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $67K | $89K |
| Current Unearned Revenue | $177K | $132K | $96K |
| Other Current Liabilities | $1.09M | $489K | $469K |
| Total Current Liabilities | $4.43M | $1.8M | $1.51M |
| Long-Term Liabilities | |||
| Long-Term Debt | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $143.63M | $128.63M |
| Total Long-Term Liabilities | $477K | $144.51M | $129.86M |
| Other Liabilities | $0 | $0 | $0 |
| Total Liabilities | $4.9M | $146.31M | $131.37M |
| Stockholders' Equity | |||
| Preferred Stock | $0 | $79.68M | $64.68M |
| Common Stock | $47K | $2K | $2K |
| Retained Earnings | -$155.66M | -$130.35M | -$110.45M |
| Comprehensive Income & Other | $0 | $0 | $0 |
| Other Stockholders' Equity | $168.88M | $838K | $607K |
| Total Equity | $13.26M | -$129.51M | -$109.84M |
| Minority Interest | $0 | $0 | $0 |
| Total Liabilities and Equity | $18.16M | $16.8M | $21.53M |
| Supplementary Data | |||
| Total Debt | $887K | $1.24M | $1.51M |
| Net Debt | -$9.22M | -$8.08M | -$13.04M |
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Operating Activities | |||
| Net Income | -$25.32M | -$19.9M | -$11.3M |
| Depreciation & Amortization | $567K | $521K | $388K |
| Deferred Income Tax | $0 | $0 | $0 |
| Stock-Based Compensation | $826K | $156K | $43K |
| Changes in Working Capital: | |||
| Accounts Receivable | -$478K | -$176K | $7K |
| Inventory | -$358K | -$434K | -$673K |
| Accounts Payable | $376K | $388K | $202K |
| Other Working Capital | $1.65M | -$759K | $625K |
| Total Working Capital Change | $1.19M | -$981K | $161K |
| Other Non-Cash Items | -$130K | $111K | -$89K |
| Net Cash from Operating | -$22.86M | -$20.09M | -$10.8M |
| Investing Activities | |||
| Capital Expenditures | -$90K | -$153K | -$754K |
| Acquisitions | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 |
| Net Cash from Investing | -$90K | -$153K | -$754K |
| Financing Activities | |||
| Debt Repaid | - | - | - |
| Common Stock Issuance | $26.79M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing Activities | -$3.18M | $75K | $174K |
| Net Cash from Financing | $23.6M | $15.07M | $20.53M |
| Forex Effect | $143K | -$71K | $37K |
| Net Change in Cash | $793K | -$5.24M | $9.01M |
| Supplementary Data | |||
| Operating Cash Flow | -$22.86M | -$20.09M | -$10.8M |
| Capital Expenditure | -$90K | -$153K | -$754K |
| Free Cash Flow | -$22.95M | -$20.24M | -$11.56M |
| Cash at Beginning | $9.32M | $14.56M | $5.55M |
| Cash at End | $10.11M | $9.32M | $14.56M |